Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, ovarian serous adenocarcinoma, peritoneal carcinoma	Active, not recruiting	Phase 2	2026-04-01		NCT05605535

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CanariaBio Inc.	4
Raptim Research	2

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amrita Institute of Medical Sciences	Kochi	India	8
Himalaya Cancer Hospital and Research Institute	Vadodara	India	1
Institute of Medical Sciences, BHU	Varanasi	India	1
JIPMER	Puducherry	India	2
Kailash Cancer Hospital and Research Centre	Vadodara	India	1
King George Hospital	Visakhapatnam	India	1
King Georges Medical University	Lucknow	India	1
KLES Dr. Prabhakar Kore Hospital and Medical Research Centre	Belagavi	India	2
MNJ Cancer Hospital	Hyderabad	India	1
Omega Hospitals	Visakhapatnam	India	1
Regional Cancer Centre, Medical College	Trivandrum	India	1
Saveetha Medical College and Hospitals	Chennai	India	1
Sri Ram Cancer Hospital	Jaipur	India	1
Sri Ramchandra Medical Centre	Chennai	India	1